课题基金 / 基金详情

项目摘要

项目成果

David M Allman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The factors underlying the formation of long-lived antibody secreting cells (ASCs) or plasma cells are unknown. The main objective of this R21 application is to establish whether ASCs that form during the earliest phases of the humoral immune response to T cell dependent (TD) and T cell independent (TI) antigens are long-lived. The proposed experiments will follow from preliminary data suggesting that both TD and TI antigens elicit the formation of long-lived ASCs. Additional experiments will test whether ASCs that form in response to T cell independent antigen require migration into the bone marrow to become long-lived. We will address these questions using a combination of normal and genetically manipulated mouse lines. Specifically we will: 1) Define the lifespan of early ASCs produced via primary TI and TD antigens, and 2) Define the lifespan of TI-1 antigen-induced ASCs retained in the spleen. PUBLIC HEALTH RELEVANCE: The factors underlying the generation of long-lived antibody secreting plasma cells are not understood. Our studies will challenge current dogma that T cell independent antigens fail to induce the formation of long-lived plasma cells. These studies have direct implications for therapeutic strategies to combat antibody-mediated autoimmune diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biochemical Mechanisms for Sustained Humoral Immunity
  • 批准号:
    10637251
  • 项目类别:
  • 资助金额:
    $64.81万
  • 财政年份:
    2023
  • 负责人:
    David M Allman
  • 依托单位:
The Notch Pathway in Antigen Design
  • 批准号:
    10575892
  • 项目类别:
  • 资助金额:
    $26.4万
  • 财政年份:
    2023
  • 负责人:
    David M Allman
  • 依托单位:
Plasma Cell Regulation by Purinergic Receptors
  • 批准号:
    10441466
  • 项目类别:
  • 资助金额:
    $20.31万
  • 财政年份:
    2021
  • 负责人:
    David M Allman
  • 依托单位:
Plasma Cell Regulation by Purinergic Receptors
  • 批准号:
    10240081
  • 项目类别:
  • 资助金额:
    $24.38万
  • 财政年份:
    2021
  • 负责人:
    David M Allman
  • 依托单位:
海外基金